ProQR Therapeutics N.V.

US$1.35As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PRQRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (12.59%)
Div yield —
ROE (57.40%)
Biotechnology
Beta (5Y) 0.27
PE TTM —
TSR TTM (50.91%)
Mkt cap US$190.5M
ROIC (29.99%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.58
17.31%
(48.81%)
Hold 2|4|5|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.01
0.01
0.01
0.01
(7.91%)
0.05%
3.17%
13.39%
Revenue€M
20.66
21.67
21.14
21.39
11.37%
14.22%
7.71%
7.68%
Peers (US$190.5M)
Cap (US$)
PE
1.522B
—
875.4M
43.62x
191.9M
—
Capital
TTM
5Y
10Y
Leveragex
1.217
0.267
0.179
EBIT/Intx
1.006
0.314
0.276
Own earn%
36.06
(80.77)
(66.14)
Sh yield%
27.86
32.75
32.84
Owners
Insiders/Inst%
10.13
63.52
Short interest%
4.24
SBC / revenue%
4.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
11–17
$1 testx
—
Incr. ROIC%
2